In 2021, the breast reconstruction market accounted for $584.7 million, which is expected to generate $1,018.6 million by 2030, growing at a 6.4% CAGR from 2021 to 2030. Furthermore, the German market holds the largest share of revenue in Europe, which is expected to expand at a 6.6% rate in the coming year. The increasing technical advancements, awareness of reconstructive methods, and growing incidences of breast cancer are all contributing to the market expansion.
Breast implants had the biggest breast reconstruction market share in 2021, and it will grow at a 6.6% CAGR from 2021 to 2030. Patients frequently choose implants in the breast reconstruction procedure owing to the shorter surgery time and absence of donor locations. Furthermore, numerous women prefer reconstruction procedures to restore their breasts' natural form. It is because of the rise in the number of breast reconstruction procedures performed and the incidence of breast cancer in countries like India, South Africa, and China.
In comparison to subglandular and submuscular insertion, the dual-plane insertion category has the larger market share. This procedure helps breast implants sit in their most natural position possible as well as alters them to provide proper soft-tissue covering. When opposed to a single-pocket site, this location offers greater benefits and fewer problems. This helps the breast gland to appropriately cover the mound generated below the muscle by the implant. The procedure takes 24 hours to recuperate.
Breast cancer is most commonly found in women, and it is cured by a mastectomy, which involves surgically removing the whole breast. Following the loss of natural breasts, breast reconstruction operations are utilized to restore the breasts. The two major procedures employed in these operations are flap or autologous reconstruction and implant reconstruction. Women are choosing reconstruction treatments to recover the natural form of the breasts after a mastectomy due to the increased incidence of breast cancer throughout the world.
With a revenue share of roughly 55% in 2030, North America is predicted to dominate the breast reconstruction market in the coming years. The surging breast augmentation procedures and increasing incidences of breast cancer are the primary drivers driving the market growth. Governments are also working on implementing different initiatives to raise awareness about the implant process, which promotes the need for breast reconstruction. As per the American Cancer Society, in 2022, Women will be diagnosed with 287,850 new instances of invasive breast cancer in the U.S.
Furthermore, the U.K. has the second-largest share in the European breast reconstruction market. Breast augmentation surgery, which involves the placement of implants underneath the breast tissue to enhance the shape or size of the breasts, is one of the most often done procedures in the country. Moreover, favorable policies are predicted to raise public awareness of breast cancer, which will likely fuel market development in the coming years. As per the breast Cancer Now, in the U.K., approximately 370 men and 55,000 women are identified with breast cancer per year.
Hence, owing to the lack of donor sites and decreased surgical duration, most the patients usually prefer implants for breast reconstruction which will fuel the market in the coming years.